| Hunter Robert Edwin Warner, LAT, ATC | |
|
917 Kalanianaole Hwy, Kailua, HI 96734-4600 | |
| (401) 222-9662 | |
| Not Available |
| Full Name | Hunter Robert Edwin Warner |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 917 Kalanianaole Hwy, Kailua, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609394543 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 001074 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hunter Robert Edwin Warner, LAT, ATC 56 Park Ave, Westerly, RI 02891-1948 Ph: (401) 222-9662 | Hunter Robert Edwin Warner, LAT, ATC 917 Kalanianaole Hwy, Kailua, HI 96734-4600 Ph: (401) 222-9662 |
News Archive
Philippine Rep. Nerissa Corazon Soon Ruiz recently introduced a measure that would amend the country's 1998 AIDS Prevention and Control Act in an effort to strengthen prevention and care services, the Manila Standard reports.
Collaborating scientists at The Scripps Research Institute (TSRI), the National Institutes of Health (NIH) and the University of Camerino in Italy have published new findings on a system in the brain that naturally moderates the effects of stress.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
› Verified 2 days ago
Lauren Lacerdo, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2 Aarona Pl Ste 202, Kailua, HI 96734 Phone: 808-263-4343 Fax: 808-263-4241 | |
Dr. Christopher Anthony Taylor, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 407 Uluniu St, Suite 201, Kailua, HI 96734 Phone: 808-261-7246 Fax: 808-261-7248 | |
Michael S. Jaffe, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 40 Aulike St Ste 317, Kailua, HI 96734 Phone: 808-744-6638 Fax: 808-744-7502 | |
Ms. Kerrey Lin Barton Taylor, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 407 Uluniu St, Suite 201, Kailua, HI 96734 Phone: 808-261-7246 Fax: 808-261-7248 | |
Kristiana Lazarova, FNP Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 970 N Kalaheo Ave Ste C316, Kailua, HI 96734 Phone: 808-488-5555 | |
Victor Riveiro Cruz, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 407 Uluniu St, Kailua, HI 96734 Phone: 808-261-4321 |